AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Tandem Diabetes Care, Inc.
XNAS · usd
SIC 3841 · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
FIGI BBG001TG5QC4
17.43▲ 0.28 (1.63%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
17.15
Day's Range
16.89 – 17.56
52-Week Range
12.26 – 29.65
Volume
1.8M
Avg Volume
2.2M
Share Statistics
Shares Outstanding
Employees
2,500
Exchange
XNAS
Listed
2013-11-14
Share count as of August 3, 2026

Tandem Diabetes Care, Inc. (TNDM) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Tandem Diabetes Care, Inc. (TNDM)
What is Tandem Diabetes Care, Inc.'s Market Cap?
Tandem Diabetes Care, Inc.'s Market Cap is $1.2B, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s Enterprise Value?
Tandem Diabetes Care, Inc.'s Enterprise Value is $1.4B, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s Price / Sales?
Tandem Diabetes Care, Inc.'s Price / Sales is 1.2×, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s EV / Revenue?
Tandem Diabetes Care, Inc.'s EV / Revenue is 1.3×, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s EV / EBITDA?
Tandem Diabetes Care, Inc.'s EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s Revenue (TTM)?
Tandem Diabetes Care, Inc.'s Revenue (TTM) is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s Net Income (TTM)?
Tandem Diabetes Care, Inc.'s Net Income (TTM) is -$63.3M, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s EBITDA?
Tandem Diabetes Care, Inc.'s EBITDA is -$27.8M, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s Diluted EPS (TTM)?
Tandem Diabetes Care, Inc.'s Diluted EPS (TTM) is -0.91, based on as-reported figures from SEC (XBRL) filings.
What is Tandem Diabetes Care, Inc.'s EBITDA Margin?
Tandem Diabetes Care, Inc.'s EBITDA Margin is -2.7%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TNDMAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Sales
YoY growth+5.8%+5.5%+2.7%+2.2%
Cost of sales
Gross profit
% of revenue56.9%55.3%57.7%53.9%
Operating expenses:
Selling, general and administrative
Research and development
Acquired in-process research and development expenses
Litigation and settlement expense—
Total operating expenses
% of revenue62.3%62.4%54.8%63.1%
Operating loss
% of revenue-5.4%-7.1%2.9%-9.2%
Other income (expense), net:
Interest income and other income, net
Interest expense
Loss from equity method investment
Total other income (expense), net
Loss before income taxes
Income tax expense (benefit)
Net loss
% of revenue-8.3%-8.2%-0.2%-8.5%
Net loss per share - basic (in dollars per share)
Net loss per share - diluted (in dollars per share)